×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| LYKA LABS LTD. | 346.24 | 27.04 | 337.98 | 0.75 | 423.0 | 103.0 |
| KERALA AYURVEDA LTD. | 313.58 | -26.96 | 311.27 | -2.40 | 415 | 346.0 |
| VENUS REMEDIES LTD. | 1788.9 | 196 | 1768.6 | 14.66 | 415 | 14.9 |
Lyka Labs Ltd.,, with Security Code 500259, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.8 | 22.1 | 17.1 | 19.4 | 21.2 | 26.7 | 31.4 | 26.9 | 30.1 | 41.1 |
| Expenses | 16.0 | 17.4 | 14.9 | 16.7 | 18.7 | 22.8 | 25.6 | 24.8 | 26.1 | 35.8 |
| Operating Profit | 5.9 | 4.7 | 2.2 | 2.7 | 2.6 | 3.9 | 5.9 | 2.2 | 4.1 | 5.3 |
| OPM % | 27.06% | 21.38% | 12.95% | 14.04% | 12.04% | 14.7% | 18.63% | 8.21% | 13.47% | 12.97% |
| Other Income | 0.7 | 0.9 | -5.8 | 0.5 | 0.4 | 0.3 | 0.5 | 0.4 | 0.6 | 0.1 |
| Interest | 2.8 | 2.9 | 3.0 | 2.8 | 1.3 | 1.2 | 1.3 | 1.0 | 0.7 | 0.5 |
| Depreciation | 3.4 | 3.5 | 3.3 | 3.3 | 3.3 | 3.5 | 2.7 | 2.8 | 1.7 | 1.7 |
| Profit before tax | 0.4 | -0.6 | -3.0 | -2.8 | -1.7 | -0.4 | 2.4 | -1.2 | 2.3 | 3.3 |
| Tax % | 15.7% | -46.1% | -2.8% | -2.6% | -2.2% | -33.4% | 43.2% | -33.8% | 25.4% | 24.3% |
| Net Profit | 0.3 | -0.4 | -10.2 | -3.0 | -1.7 | -0.3 | 1.4 | -1.6 | 1.8 | 2.5 |
| EPS in Rs | 0.11 | -0.15 | -3.57 | -1.05 | -0.54 | -0.1 | 0.4 | -0.5 | 0.49 | 0.69 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.5 | 17.8 | 22.2 | 22.9 | 28.0 | 32.6 | 27.8 | 30.1 | 41.2 | 33.8 |
| Expenses | 20.5 | 15.6 | 18.9 | 20.2 | 23.8 | 25.9 | 25.7 | 26.4 | 36.2 | 28.6 |
| Operating Profit | 5.0 | 2.2 | 3.3 | 2.6 | 4.2 | 6.6 | 2.0 | 3.7 | 5.0 | 5.2 |
| OPM % | 19.7% | 12.4% | 14.8% | 11.6% | 14.9% | 20.4% | 7.3% | 12.3% | 12% | 15.4% |
| Other Income | 1.0 | -5.9 | 0.0 | 0.4 | -0.2 | 0.5 | 0.3 | 0.6 | 0.0 | 0.8 |
| Interest | 3.0 | 3.1 | 2.8 | 1.4 | 1.2 | 1.3 | 1.1 | 0.6 | 0.5 | 0.6 |
| Depreciation | 3.6 | 3.5 | 3.5 | 3.5 | 3.6 | 2.8 | 2.9 | 1.8 | 1.8 | 1.8 |
| Profit before tax | -0.4 | -3.3 | -2.6 | -1.8 | -0.4 | 3.1 | -1.7 | 1.9 | 2.7 | 3.6 |
| Tax % | -46.7% | -2.3% | -0.1% | -7.3% | -22.3% | 38.7% | -28.2% | 30.8% | 28.5% | 24.3% |
| Net Profit | -0.4 | -10.5 | -3.0 | -1.9 | -0.6 | 1.8 | -2.1 | 1.3 | 2.1 | 2.7 |
| EPS in Rs | 0 | -3 | -1 | 0 | 0 | 0 | -3 | 0 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 21% |
| 3 Years: | 20% |
| TTM: | 33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 22% |
| TTM: | 251% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 46% |
| 3 Years: | -6% |
| 1 Year: | -5% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 9% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 7% |
| 3 Years: | 19% |
| TTM: | 243% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 46% |
| 3 Years: | -6% |
| 1 Year: | -5% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|